Article
The impact of EGFR mutation status on outcomes in patients with resected stage I non-small cell lung cancers.
The Annals of thoracic surgery - 1 Sept 2013
Izar Benjamin, Sequist Lecia, Lee Mihan, Muzikansky Alona, Heist Rebecca, Iafrate John, Dias-Santagata Dora, Mathisen Douglas, Lanuti Michael
Abstract excerpt
BACKGROUND: Mutations of the epidermal growth factor hormone receptor (EGFR) gene have been associated with improved treatment response and prognosis in advanced non-small lung cancer (NSCLC). However, their prognostic role in early-stage NSCLC is not well defined. In this study we sought to identify the pure prognostic role of EGFR mutation in patients with completely resected stage I NSCLC who received no...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
